Related Experiment Videos
Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients
N Katkhouda1, M B Hurwitz, R T Rivera
1Department of Surgery, University of Southern California School of Medicine, Los Angeles, USA.
Annals of Surgery
|October 28, 1998
Summary
Laparoscopic splenectomy (LS) is a safe and effective treatment for benign hematologic disorders. This minimally invasive procedure shows high success rates in resolving conditions like ITP and hereditary spherocytosis.
Area of Science:
- Minimally invasive surgery
- Gastrointestinal surgery
- Hematology
Background:
- Laparoscopic splenectomy (LS) feasibility is established, but efficacy data in large patient cohorts are limited.
- Benign hematologic disorders often require splenectomy for management.
Purpose of the Study:
- To evaluate the safety and efficacy of laparoscopic splenectomy (LS) in patients with benign hematologic disorders.
Main Methods:
- Prospective data collection from 103 consecutive patients undergoing LS between June 1992 and October 1997.
- Analysis of indications, spleen characteristics, operative details, complications, and patient outcomes.
Main Results:
- No deaths occurred; complications were infrequent (6%), with one requiring reoperation.
- Significant improvements observed: 84% resolution of thrombocytopenia in ITP, 70% hematocrit increase in hemolytic anemias, and 92% positive response in hereditary spherocytosis.
- Mean operative time decreased over the study period, and mean postsurgical stay was 2.5 days.
Conclusions:
- Laparoscopic splenectomy (LS) is a safe and effective procedure in a teaching hospital setting.
- Careful technique minimizes complications like splenosis, and localization of accessory spleens improves outcomes.
- LS is recommended as the preferred surgical approach for intractable benign hematologic diseases.